{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:28:04Z","timestamp":1767677284480,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s40262-019-00752-6","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T07:18:22Z","timestamp":1554362302000},"page":"1345-1350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1512-6530","authenticated-orcid":false,"given":"Dario","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Minisci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Meraviglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Astuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Fusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Gervasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"752_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/17425255.2018.1421172","volume":"14","author":"S Stefanovi\u0107","year":"2018","unstructured":"Stefanovi\u0107 S, Jankovi\u0107 SM, Novakovi\u0107 M, Milosavljevi\u0107 M, Foli\u0107 M. Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs. Expert Opin Drug Metab Toxicol. 2018;14:153\u20139.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"752_CR2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","volume":"16","author":"G Zaccara","year":"2014","unstructured":"Zaccara G, Perucca E. Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord. 2014;16:409\u201331.","journal-title":"Epileptic Disord."},{"key":"752_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40262-013-0088-z","volume":"52","author":"PN Patsalos","year":"2013","unstructured":"Patsalos PN. Drug interactions with the newer antiepileptic drugs (AEDs)\u2014part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders. Clin Pharmacokinet. 2013;52:1045\u201361.","journal-title":"Clin Pharmacokinet."},{"key":"752_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40262-013-0087-0","volume":"52","author":"PN Patsalos","year":"2013","unstructured":"Patsalos PN. Drug interactions with the newer antiepileptic drugs (AEDs)\u2014part 1: pharmacokinetic and pharmacodynamic interactions between AEDs. Clin Pharmacokinet. 2013;52:927\u201366.","journal-title":"Clin Pharmacokinet."},{"key":"752_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1528-1167.2011.03335.x","volume":"53","author":"GL Birbeck","year":"2012","unstructured":"Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, Quality Standards Subcommittee of the American Academy Of Neurology, Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy, et al. Antiepileptic drug selection for people with HIV\/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia. 2012;53:207\u201314.","journal-title":"Epilepsia."},{"key":"752_CR6","first-page":"467","volume":"12","author":"AK Sarma","year":"2016","unstructured":"Sarma AK, Khandker N, Kurczewski L, Brophy GM. Medical management of epileptic seizures: challenges and solutions. Neuropsychiatr Dis Treat. 2016;12:467\u201385.","journal-title":"Neuropsychiatr Dis Treat."},{"key":"752_CR7","first-page":"10","volume":"5","author":"BF Kirmani","year":"2014","unstructured":"Kirmani BF, Mungall-Robinson D. Role of anticonvulsants in the management of AIDS related seizures. Front Neurol. 2014;5:10.","journal-title":"Front Neurol."},{"key":"752_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1345\/aph.1D309","volume":"38","author":"MD Liedtke","year":"2004","unstructured":"Liedtke MD, Lockhart SM, Rathbun RC. Anticonvulsant and antiretroviral interactions. Ann Pharmacother. 2004;38:482\u20139.","journal-title":"Ann Pharmacother."},{"key":"752_CR9","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2174\/1381612033454676","volume":"9","author":"F Romanelli","year":"2003","unstructured":"Romanelli F, Pomeroy C. Concurrent use of antiretrovirals and anticonvulsants in human immunodeficiency virus (HIV) seropositive patients. Curr Pharm Des. 2003;9:1433\u20139.","journal-title":"Curr Pharm Des."},{"key":"752_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51:9\u201362.","journal-title":"Pharmacopsychiatry."},{"key":"752_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2018.1500032","author":"D Cattaneo","year":"2018","unstructured":"Cattaneo D, Baldelli S, Resnati C, Giacomelli A, Meraviglia P, Minisci D, et al. Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: potential implications for clinical practice. World J Biol Psychiatry. 2018. \n                    https:\/\/doi.org\/10.1080\/15622975.2018.1500032\n                    \n                  \n                           (Epub 20 Sep 2018).","journal-title":"World J Biol Psychiatry"},{"key":"752_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1515\/cclm-2014-0472","volume":"53","author":"S Baldelli","year":"2015","unstructured":"Baldelli S, Cattaneo D, Giodini L, Baietto L, Di Perri G, D\u2019Avolio A, et al. Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots. Clin Chem Lab Med. 2015;53:435\u201344.","journal-title":"Clin Chem Lab Med."},{"key":"752_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40268-016-0148-6","volume":"16","author":"S Jacob","year":"2016","unstructured":"Jacob S, Nair AB. An updated overview on therapeutic drug monitoring of recent antiepileptic drugs. Drugs R D. 2016;16:303\u201316.","journal-title":"Drugs R D."},{"key":"752_CR14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1684\/epd.2016.0880","volume":"18","author":"CJ Landmark","year":"2016","unstructured":"Landmark CJ, Johannessen SI, Tomson T. Dosing strategies for antiepileptic drugs: from a standard dose for all to individualised treatment by implementation of therapeutic drug monitoring. Epileptic Disord. 2016;18:367\u201383.","journal-title":"Epileptic Disord."},{"issue":"Suppl 1","key":"752_CR15","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1046\/j.1365-2125.2001.00394.x","volume":"52","author":"MJ Eadie","year":"2001","unstructured":"Eadie MJ. Therapeutic drug monitoring: antiepileptic drugs. Br J Clin Pharmacol. 2001;52(Suppl 1):11S\u201320S.","journal-title":"Br J Clin Pharmacol."},{"key":"752_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1389200216666150602145005","volume":"16","author":"R Mandrioli","year":"2015","unstructured":"Mandrioli R, Protti M, Mercolini L. Novel atypical antipsychotics: metabolism and therapeutic drug monitoring (TDM). Curr Drug Metab. 2015;16:141\u201351.","journal-title":"Curr Drug Metab."},{"key":"752_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2478\/acph-2014-0036","volume":"64","author":"M Grundmann","year":"2014","unstructured":"Grundmann M, Kacirova I, Urinovska R. Therapeutic drug monitoring of atypical antipsychotic drugs. Acta Pharm. 2014;64:387\u2013401.","journal-title":"Acta Pharm."},{"key":"752_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/FTD.0b013e3182708ec5.","volume":"34","author":"L Patteet","year":"2012","unstructured":"Patteet L, Morrens M, Maudens KE, Niemegeers P, Sabbe B, Neels H. Therapeutic drug monitoring of common antipsychotics. Ther Drug Monit. 2012;34:629\u201351.","journal-title":"Ther Drug Monit."},{"issue":"3","key":"752_CR19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/jac\/dkx461","volume":"73","author":"A Palazzo","year":"2018","unstructured":"Palazzo A, Trunfio M, Pirriatore V, Milesi M, De Nicol\u00f2 A, Alcantarini C, et al. Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid. J Antimicrob Chemother. 2018;73(3):826\u20137.","journal-title":"J Antimicrob Chemother."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00752-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-019-00752-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00752-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T23:07:14Z","timestamp":1585868834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-019-00752-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1007\/s40262-019-00752-6","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"type":"print","value":"0312-5963"},{"type":"electronic","value":"1179-1926"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"assertion":[{"value":"4 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Cristina Gervasoni and Massimo Galli have received educational grants from Merck Sharp & Dohme (MSD), Janssen-Cilag, Bristol Myers Squibb, Boehringer Ingelheim, ViiV Healthcare and Abbvie. Paola Meraviglia has received educational grants from Merck Sharp & Dohme (MSD), Janssen-Cilag, Bristol Myers Squibb, Boehringer Ingelheim and ViiV Healthcare. Dario Cattaneo has received educational and travel grants from Merck Sharp & Dohme (MSD) and ViiV Healthcare. Sara Baldelli, Andrea Giacomelli, Davide Minisci, Noemi Astuti, Marta Fusi, Valeria Cozzi, and Emilio Clementi declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}